Achieve begins multi-dose study of cytisine for smoking cessation

US-based specialist pharmaceutical firm Achieve Life Sciences has begun a multi-dose study to evaluate both pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of cytisine, a plant-based alkaloid with a high-binding affinity to the nicotini …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news